Genkyotex Announces First-half 2020 Results and Business Update
(WorldNews France)

Genkyotex Announces First-half 2020 Results and Business Update 17 Sep 2020 18:25 CEST Company Name GENKYOTEX ISN FR0013399474 Market Euronext Symbol GKTX Cash and cash equivalents of €5.1 million at June 30, 2020 First patient enrolled in Phase 2 trial of setanaxib in IPF Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX)(Euronext Paris & Brussels: FR0013399474 - GKTX), a biopharmaceutical company and leader in NOX therapies, today provides business update and announces its consolidated financial results for the six months ended June 30, 2020, prepared in accordance with IFRS. Business update and outlook The Company announced on August 13, 2020 an agreement for Calliditas Therapeutics...